In addition, scratch-wound and transwell migration assays showed that TGFβ, HGF, or both markedly increased cancer cell migration and invasion, and these effects were abolished by crizotinib (Fig. 5b, c and Supplementary Fig. 13a, b). This evidence concerns the gene TGFB1 and cancer.